Private equity (PE) has completely reshaped insurance broker distribution.
It has pumped billions of dollars into the space, giving owners a way to cash out, and pushed valuations to levels that would have sounded ridiculous 15 years ago. From about 2010–2020, PE money helped firms scale, cleanup operations, and sell at eye-popping EBITDA multiples.
But here’s the part that doesn’t make the glossy pitch deck: selling to PE is complicated. If you don’t really understand what you’re signing up for, you can wake up a few years after closing and realize the “big win” wasn’t nearly as big as you thought.
How We Got Here: PE in Insurance Distribution
During the 2010s, PE rushed into broker distribution. The playbook was simple:
- Buy platforms in a fragmented market
- Roll up add-on acquisitions
- Layer in process, data, and discipline
- Use cheap debt to juice returns
Low interest rates, tons of available capital, and strong industry fundamentals created a perfect storm. Deals got bigger, multiples got richer, and a lot of people made a lot of money. It also quietly rewired how brokerages are bought, sold, and run.
In practice, there are two main ways PE shows up in your world:
1. Direct sale to a PE firm
The PE fund buys an equity stake in your company. Expect:
- Tighter governance
- More reporting
- A real say from your new minority (or majority) partner on strategy and capital allocation
2. Sale to a PE‑backed platform (most common)
You sell to a company that’s already owned by PE. You usually walk away with:
- A big cash payout up front (say about 80%)
- Stock in the platform you’re joining (often approximately 20%)
This second route is where most of the upside stories live. For example, over the past decade it wasn’t uncommon for the roughly 20% rollover equity a seller took to be worth more than the roughly 80% cash payout they received just five years earlier.
How PE Actually Gets Involved
In a PE‑backed sale, you are not investing in the PE fund itself. You’re becoming a shareholder in the platform company they control.
Historically (think 2013–2019), that equity piece often turned into a very nice “second bite at the apple.” As the platform grew and repriced at higher multiples, sellers who rolled equity made serious money.
But those outcomes rode on a huge tailwind: cheap debt and easy leverage. Once rates started climbing in 2022, that leverage suddenly cut both ways.
Why Selling to a PE-Backed Buyer Is Different
To boost returns, many sponsors leaned hard on debt. Then some went a step further and added preferred equity on top.
Preferred equity is a hybrid:
- It sits in front of common equity in the payout line.
- It usually has a contractual return attached to it.
- Preferred holders get paid before the common stockholders see a dollar.
When used well, preferred equity can dramatically boost returns for common shareholders. But it cuts both ways—if growth stalls or market valuations soften, preferred holders can strip most of the upside from common equity.
Where Things Get Complicated: Leverage, Preferred Equity, and Valuations
1. Priority of returns
Preferred investors are at the front of the line. If they’ve got a rich coupon or a big accrued return, they can soak up a huge chunk of the exit value before common equity gets anything meaningful.
2. Misleading headline valuations
This is where it gets dangerous:
- You hear: “The deal is at 20x EBITDA.”
- What’s not obvious:
- There’s preferred equity with a guaranteed return.
- There may be options, warrants, or other sweeteners favoring the sponsor.
- The structure is designed to protect the preferred and amplify their economics.
On paper, the valuation looks fantastic. In reality, once the preferred stack and sponsor economics are paid, the residual value for common may be far lower than the headline suggests.
And because:
- Many sellers never see the full waterfall, and
- The terms of preferred instruments aren’t always pushed front and center
…it’s easy to dramatically overestimate what your equity is actually worth.
To be clear, preferred equity isn’t bad in and of itself. Used properly, it can bridge valuation gaps, protect downside, and align incentives. The real risk is going in blind—rolling stock without understanding where you sit in the capital stack.
Learn how to navigate the risks of selling to private equity.
